205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
0.02%
Revenue growth below 50% of MCHP's 4.63%. Michael Burry would check for competitive disadvantage risks.
5.92%
Cost growth above 1.5x MCHP's 3.42%. Michael Burry would check for structural cost disadvantages.
-3.26%
Gross profit decline while MCHP shows 5.21% growth. Joel Greenblatt would examine competitive position.
-3.29%
Margin decline while MCHP shows 0.56% expansion. Joel Greenblatt would examine competitive position.
-1.26%
R&D reduction while MCHP shows 5.14% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.60%
Operating expenses reduction while MCHP shows 2.22% growth. Joel Greenblatt would examine advantage.
3.17%
Total costs growth 1.1-1.25x MCHP's 2.84%. Bill Ackman would demand justification.
10.11%
Interest expense growth while MCHP reduces costs. John Neff would investigate differences.
6.67%
D&A growth while MCHP reduces D&A. John Neff would investigate differences.
-2.13%
EBITDA decline while MCHP shows 4.73% growth. Joel Greenblatt would examine position.
-2.15%
EBITDA margin decline while MCHP shows 0.09% growth. Joel Greenblatt would examine position.
-4.06%
Operating income decline while MCHP shows 7.48% growth. Joel Greenblatt would examine position.
-4.08%
Operating margin decline while MCHP shows 2.73% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
-4.00%
Pre-tax income decline while MCHP shows 9.03% growth. Joel Greenblatt would examine position.
-4.02%
Pre-tax margin decline while MCHP shows 4.20% growth. Joel Greenblatt would examine position.
-23.93%
Tax expense reduction while MCHP shows 18.97% growth. Joel Greenblatt would examine advantage.
-0.75%
Net income decline while MCHP shows 6.24% growth. Joel Greenblatt would examine position.
-0.78%
Net margin decline while MCHP shows 1.54% growth. Joel Greenblatt would examine position.
-0.53%
EPS decline while MCHP shows 7.07% growth. Joel Greenblatt would examine position.
-1.07%
Diluted EPS decline while MCHP shows 6.12% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.